Pharmacokinetic equivalence and comparative safety, tolerability, and immunogenicity of Biocon’s ustekinumab (Bmab-1200) with EU-approved and US-licensed reference ustekinumab in healthy subjects: results from the Study to Test pharmacokinetic BioEqu

Authors

Institutions

Publication Details

Journal
Expert Opinion on Investigational Drugs
Published
2025-04-03
DOI
https://doi.org/10.1080/13543784.2025.2500334
Citations
4
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
article
Field-Weighted Citation Impact
3.19
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacokinetic equivalence and comparative safety, tolerability, and immunogenicity of Biocon’s ustekinumab (Bmab-1200) with EU-approved and US-licensed reference ustekinumab in healthy subjects: results from the Study to Test pharmacokinetic BioEqu

Sarika Deodhar, Gursharan Singh, Subramanian Loganathan, Sandeep N. Athalye et al.
4 citations
Expert Opinion on Investigational Drugs
Immunodeficiency and Autoimmune Disorders
3.19
article

Pharmacokinetic equivalence and comparative safety, tolerability, and immunogenicity of Biocon’s ustekinumab (Bmab-1200) with EU-approved and US-licensed reference ustekinumab in healthy subjects: results from the Study to Test pharmacokinetic BioEqu

Sarika Deodhar, Gursharan Singh, Subramanian Loganathan, Sandeep N. Athalye, Ashwani Marwah, J F Ackroyd, Kuldeep Kumar, Jayanti Panda
article en
4 citations

Abstract

No abstract available for this paper.
Expert Opinion on Investigational DrugsVol. 34(4)
Biocon (India) (IN)
Openalex Percentile: Top 8%
Immunodeficiency and Autoimmune Disorders
3.19
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.